Palarium Palbociclib 75 mg Capsules 21's is a prescription oral oncology medicine identified as containing Palbociclib 75 mg per capsule.

The stated pack size is 21 capsules.

Palbociclib is a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor used as targeted anticancer therapy.

It is used with endocrine therapy in selected hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2-negative (HER2-negative) advanced or metastatic breast cancer treatment settings.

Palbociclib interferes with cell-cycle progression by inhibiting CDK4 and CDK6.

This can slow the proliferation of susceptible cancer cells.

The 75 mg capsule strength does not represent a universal patient dose.

The exact manufacturer, capsule composition, storage conditions and approved indications of Palarium must be verified from its approved Indian product documentation.

Marketed by Essentials Emporium Enterprises, Palarium is listed within the oncology pharmaceutical category for hospitals, cancer treatment centres and authorized pharmaceutical buyers.

Key Product Features